scholarly article | Q13442814 |
P50 | author | Franco Folli | Q57078092 |
Ralph A. DeFronzo | Q58689309 | ||
Raul A Bastarrachea | Q61785527 | ||
Gary W Cline | Q88551066 | ||
Anthony G Comuzzie | Q114358626 | ||
Vicki Mattern | Q114358642 | ||
Amalia Gastaldelli | Q43294287 | ||
P2093 | author name string | Devjit Tripathy | |
Edward J Dick | |||
Alberto O Chavez | |||
Alberto M Davalli | |||
Lilia M Jimenez-Ceja | |||
Francesca Casiraghi | |||
Glenn A Halff | |||
Paul B Higgins | |||
Rodolfo Guardado-Mendoza | |||
Andrea Ricotti | |||
Iram Pablo Rodriguez-Sanchez | |||
Subhash Kamath | |||
Gregory A Abrahamian | |||
Ana Maria Paez | |||
Mary E Tejero | |||
P2860 | cites work | Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. | Q51413742 |
Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. | Q51466405 | ||
Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. | Q55033199 | ||
Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution | Q60225390 | ||
Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways | Q77807989 | ||
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice | Q28254441 | ||
Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease | Q28571421 | ||
Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice | Q28593025 | ||
Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
Liver fibrosis | Q29547449 | ||
Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissue | Q33359272 | ||
Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy | Q33527670 | ||
Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort | Q33691736 | ||
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. | Q33910338 | ||
Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model | Q34021867 | ||
Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance | Q34153521 | ||
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance | Q34577169 | ||
Gene expression profiling of alcoholic liver disease in the baboon (Papio hamadryas) and human liver | Q35843317 | ||
Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications | Q36304061 | ||
Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance | Q36577029 | ||
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications | Q36617551 | ||
Obesity and nonalcoholic fatty liver disease | Q36867151 | ||
Fatty liver: a novel component of the metabolic syndrome | Q36906553 | ||
Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents | Q36916878 | ||
Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake | Q37147269 | ||
Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons | Q37172937 | ||
Rhesus macaques develop metabolic syndrome with reversible vascular dysfunction responsive to pioglitazone | Q37178240 | ||
Cross-talk between the insulin and angiotensin signaling systems | Q37241991 | ||
The epidemiology of nonalcoholic fatty liver disease: a global perspective | Q37310275 | ||
Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons | Q37310707 | ||
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers | Q37439017 | ||
Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition | Q37459831 | ||
Methods for assessing intrahepatic fat content and steatosis. | Q37529087 | ||
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal | Q37578517 | ||
Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome | Q37693238 | ||
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease | Q37794163 | ||
Toll-like receptors: linking inflammation to metabolism | Q37796144 | ||
Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis | Q37869703 | ||
Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice | Q38297728 | ||
Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein | Q38348521 | ||
Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function. | Q38358299 | ||
Flavor preferences, food intake, and weight gain in baboons (Papio sp.). | Q38578837 | ||
Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. | Q39494990 | ||
Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans | Q39821210 | ||
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. | Q42462295 | ||
Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase | Q42563412 | ||
Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. | Q42825313 | ||
Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum | Q43637127 | ||
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women | Q44488009 | ||
Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease | Q44726439 | ||
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms | Q45300618 | ||
Physiological and molecular determinants of insulin action in the baboon. | Q46823836 | ||
Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies | Q46970421 | ||
Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction | Q50162855 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | triglyceride | Q186319 |
fatty acid | Q61476 | ||
insulin resistance | Q1053470 | ||
preproinsulin | Q7240673 | ||
P304 | page(s) | e27617 | |
P577 | publication date | 2011-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates | |
P478 | volume | 6 |